Share >  
Share
Share on Tumblr

Nectar Lifesciences

News »

   latest by relevance
To see robust revenue from 2013: Nectar Lifesciences
Dec 08, 2011 at 14:53 | Source: CNBC-TV18
In an interview to CNBC-TV18, DINESH DUA, chief executive officer of Nectar Lifesciences spoke about the approval it has received from European market.
API facility to boost revenue by 5-10%: Nectar Lifesciences
Oct 14, 2011 at 14:29 | Source: CNBC-TV18
Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the companys revenues by 5-10%.
Nectar Lifesciences gets European nod for Punjab plant
Oct 14, 2011 at 12:00 | Source: Moneycontrol.com
Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab.
Nectar Lifesciences receives USFDA nod for Dera Bassi plant
Sep 08, 2011 at 21:12 | Source: PTI
Nectar Lifesciences today said it has received approval from the US health regulator for its manufacturing facility at Dera Bassi in Punjab.
यूएस एफडीए से प्लांट को मंजूरीः नेक्टर लाइफ
Sep 08, 2011 at 15:30 | Source:
नेक्टर लाइफसाइंसेज के पंजाब के देरा बस्सी में एपीआई प्लांट को अमेरिकी एफडीए की मंजूरी मिल गई है।
Nectar Lifesciences manufacturing unit gets US FDA nod
Sep 08, 2011 at 14:41 | Source: Moneycontrol.com
Nectar Lifesciences has received US Food and Drugs Administration (FDA) approval for its Active Pharmaceutical Ingredients (API) manufacturing plant Unit-II in Dera Bassi, Punjab.

Videos »
To see robust revenue from 2013: Nectar Lifesciences
API facility to boost revenue by 5-10%: Nectar Lifesciences
Regulated markets to fetch Rs 250-300cr in 2 years: Nectar
USFDA nod will open up lucrative market for us: Nectar Lifesciences
Nectar Lifesciences targets Rs 1300cr revenues in FY12
more »

Photos »

  /  
News across the web »
Pharma sector seeks incentives to enhance spending in R D activities
Chandigarh, Feb 12: The pharmaceutical industry has asked the Centre to incentivise the sector to promote higher spending in research and development and bring down the taxes and duties on life-savin...
Feb 12, 2012 at 18:32 | Source: The Hindu BusinessLine
Nectar Life Q3 net up 7% at Rs 32 cr
Drug firm Nectar Lifesciences today posted an increase of 7.18% in net profit to Rs 32.38 crore for the third quarter ended December 31. The company had posted a net profit of Rs 30.21 crore for the O...
Feb 11, 2012 at 04:32 | Source: Business Standard
Nectar Life Q3 net up 7.18% at Rs 32.38 cr
New Delhi, Feb 10: Drug firm, Nectar Lifesciences, on Friday posted an increase of 7.18 per cent in net profit to Rs 32.38 crore for the third quarter ended December 31. The company had posted a net ...
Feb 10, 2012 at 20:47 | Source: The Hindu BusinessLine
Parabolic Drugs a good bet for long-term play
Shares of Chandigarh-based Parabolic Drugs - a manufacturer of active pharmaceutical ingredients, or APIs, which got listed in July 2010 - is trading at half its listing price. The stock appears to b...
Jan 03, 2012 at 04:07 | Source: Economic Times
Punjab okays 19 projects worth Rs 4,458 crore
Punjab has approved 19 projects, including those of PepsiCo India and Nectar Lifescience, which will bring investment worth Rs 4,457.77 crore in the State. The Empowered Committee chaired by the Chie...
Dec 01, 2011 at 19:02 | Source: The Hindu BusinessLine
more »
Interact & exchange stock tips & market info »

Market Statistician

Platinum Member

4327 Followers

Nectar Life  

At 14:13 hrs, Nectar Lifesciences was trading at Rs 20.5...

2.15 PM May 23rd

Market Statistician

Platinum Member

4327 Followers

Nectar Life  

At 12:14 hrs, Nectar Lifesciences was trading at Rs 20.4...

12.15 PM May 23rd

singh

Platinum Member

54 Followers

Parabolic Drugs  

crore, while Nectar Lifesciences and Parabolic Drugs su...

8.10 PM May 19th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window